Noxopharm Ltd
ASX:NOX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Noxopharm Ltd
ASX:NOX
|
AU |
|
ANTA Sports Products Ltd
F:AS7
|
CN |
|
K
|
Kung Sing Engineering Corp
TWSE:5521
|
TW |
|
Pearson PLC
LSE:PSON
|
UK |
|
U
|
Ucb SA
OTC:UCBJF
|
BE |
|
Air Products and Chemicals Inc
NYSE:APD
|
US |
|
H
|
HELLENiQ ENERGY Holdings SA
F:HLPN
|
GR |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
Prudential Financial Inc
BMV:PRU
|
US |
|
P
|
PostNL NV
XMUN:TNTC
|
NL |
|
P
|
PepsiCo Inc
BMV:PEP
|
US |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
Bankruptcy Probability
Noxopharm Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Noxopharm Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Noxopharm Ltd
ASX:NOX
|
19m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Noxopharm Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Noxopharm Ltd has total debt of 4.2m AUD. This includes both short-term (4.2m AUD) and long-term (0 AUD) debt.
You can find a full breakdown on its Balance Sheet.